Introduction to the E2F family: protein structure and gene regulation - PubMed (original) (raw)
Review
Introduction to the E2F family: protein structure and gene regulation
J E Slansky et al. Curr Top Microbiol Immunol. 1996.
Abstract
E2F is a heterodimer composed of two partners, such as E2F1 and DP1. Although E2F1 can bind DNA as a homodimer and increase promoter activity, optimal DNA-binding and transcriptional activity occurs in the heterodimeric form. A model (Fig. 3) for the involvement of E2F activity in cell growth control that incorporates viral oncoproteins, positive regulators of cell growth (cyclins) and negative regulators of cell growth (tumor suppressor proteins) can now be advanced. Each aspect of this model is addressed in subsequent chapters of this book. It is likely that binding of growth-suppressing proteins, such as Rb, can inhibit the transactivation potential of E2F1, either by blocking the interaction of E2F1 with a separate component of the transcription complex or by bringing a repressor domain to the transcription complex (Flemington et al. 1993; Helin et al. 1993; Weintraub et al. 1992; Zamanian and La Thangue 1993; Zhu et al. 1993). Phosphorylation or sequestration of Rb by viral oncoproteins can free E2F. The influence of viral oncoproteins on E2F activity and the regulation of the different E2F complexes is the focus of the contributions by Cobrinik and by Cress and Nevens. The interaction of the free E2F induces a bend in the DNA that may also play a role in transactivation, perhaps by bringing proteins (such as an Sp1 or CCAAT family member) separated by distance on the promoter DNA into contact (Huber et al. 1994). Because E2F target genes encode proteins critical for cell growth, deregulation of E2F activity can have severe consequences, such as apoptosis or uncontrolled proliferation. The effect of altered expression of E2F activity on the cell cycle and on tumorigenicity is the focus of the contribution by Adams and Kaelin. Finally, a comparison of E2F to the genetically well-characterized factors that regulate G1/S phase transcription in yeast is the subject of the chapter by Breeden. This volume concludes with Farnham's summary of the rapid gains in knowledge concerning the E2F gene family that have been made in the past several years and provides a series of questions and lines of investigation that will be the focus of future studies.
Similar articles
- Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Hsiao KM, McMahon SL, Farnham PJ. Hsiao KM, et al. Genes Dev. 1994 Jul 1;8(13):1526-37. doi: 10.1101/gad.8.13.1526. Genes Dev. 1994. PMID: 7958837 - Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Johnson DG, Ohtani K, Nevins JR. Johnson DG, et al. Genes Dev. 1994 Jul 1;8(13):1514-25. doi: 10.1101/gad.8.13.1514. Genes Dev. 1994. PMID: 7958836 - [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y. Nakajima Y. Kokubyo Gakkai Zasshi. 1998 Jun;65(2):172-88. doi: 10.5357/koubyou.65.172. Kokubyo Gakkai Zasshi. 1998. PMID: 9711036 Japanese. - The cellular effects of E2F overexpression.
Adams PD, Kaelin WG Jr. Adams PD, et al. Curr Top Microbiol Immunol. 1996;208:79-93. doi: 10.1007/978-3-642-79910-5_4. Curr Top Microbiol Immunol. 1996. PMID: 8575214 Review. - Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Inoshita S, et al. Kidney Int. 1999 Oct;56(4):1238-41. doi: 10.1046/j.1523-1755.1999.00705.x. Kidney Int. 1999. PMID: 10504464 Review.
Cited by
- Harnessing the effects of hypoxia-like inhibition on homology-directed DNA repair.
Altwerger G, Ghazarian M, Glazer PM. Altwerger G, et al. Semin Cancer Biol. 2024 Jan;98:11-18. doi: 10.1016/j.semcancer.2023.11.007. Epub 2023 Nov 28. Semin Cancer Biol. 2024. PMID: 38029867 Review. - A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer.
Li JK, Liu H, Zhang HW, Li J, Liang ZT. Li JK, et al. J Cancer. 2023 Sep 4;14(14):2739-2750. doi: 10.7150/jca.86718. eCollection 2023. J Cancer. 2023. PMID: 37779874 Free PMC article. - HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p.
Deng Y, Wang L, Zhang Y, Sun D, Min H, Zhou H, Xu C, Xu N, Qiu F, Zhou J, Zhou J. Deng Y, et al. Aging (Albany NY). 2023 Aug 1;15(15):7533-7550. doi: 10.18632/aging.204921. Epub 2023 Aug 1. Aging (Albany NY). 2023. PMID: 37531206 Free PMC article. - Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma.
Shen S, Wang Y. Shen S, et al. Int J Gen Med. 2021 Nov 18;14:8463-8472. doi: 10.2147/IJGM.S334033. eCollection 2021. Int J Gen Med. 2021. PMID: 34824545 Free PMC article. - Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways.
Whitaker RH, Cook JG. Whitaker RH, et al. Biomolecules. 2021 Oct 2;11(10):1444. doi: 10.3390/biom11101444. Biomolecules. 2021. PMID: 34680077 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous